Insider Buy/Sell Details for the Healthcare Sector — October 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (858)
HEALTHSTREAM INC (HSTM)
REBROVICK LINDA — Director
Shares
12,000
Price
$35.00
Total Value
$420.00K
Shares Held After
39,329
% of Holdings
23.4%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
273
Price
$447.19
Total Value
$122.08K
Shares Held After
19,919
% of Holdings
1.4%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
827
Price
$446.05
Total Value
$368.88K
Shares Held After
20,192
% of Holdings
3.9%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
160
Price
$444.85
Total Value
$71.18K
Shares Held After
21,019
% of Holdings
0.8%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
440
Price
$443.81
Total Value
$195.28K
Shares Held After
21,179
% of Holdings
2.0%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
480
Price
$442.61
Total Value
$212.45K
Shares Held After
21,619
% of Holdings
2.2%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
2,343
Price
$441.34
Total Value
$1.03M
Shares Held After
22,099
% of Holdings
9.6%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
1,720
Price
$440.44
Total Value
$757.56K
Shares Held After
24,442
% of Holdings
6.6%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
1,160
Price
$439.25
Total Value
$509.53K
Shares Held After
26,162
% of Holdings
4.2%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
240
Price
$438.22
Total Value
$105.17K
Shares Held After
27,322
% of Holdings
0.9%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
560
Price
$437.07
Total Value
$244.76K
Shares Held After
27,562
% of Holdings
2.0%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
1,660
Price
$436.20
Total Value
$724.09K
Shares Held After
28,122
% of Holdings
5.6%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
321
Price
$435.25
Total Value
$139.72K
Shares Held After
29,782
% of Holdings
1.1%
Elevance Health, Inc. (ELV)
Kaye Mark — EVP&CFO
Shares
400
Price
$434.00
Total Value
$173.60K
Shares Held After
30,103
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$590.40
Total Value
$94.46K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$589.50
Total Value
$141.48K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
783
Price
$588.19
Total Value
$460.55K
Shares Held After
324,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
937
Price
$587.24
Total Value
$550.24K
Shares Held After
325,626
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$586.31
Total Value
$750.47K
Shares Held After
326,563
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,756
Price
$585.24
Total Value
$1.03M
Shares Held After
327,843
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,200
Price
$584.21
Total Value
$701.06K
Shares Held After
329,599
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$583.09
Total Value
$443.15K
Shares Held After
330,799
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$581.83
Total Value
$232.73K
Shares Held After
331,559
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$581.03
Total Value
$209.17K
Shares Held After
331,959
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$579.69
Total Value
$92.75K
Shares Held After
332,319
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$578.59
Total Value
$92.57K
Shares Held After
332,479
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$577.28
Total Value
$161.64K
Shares Held After
332,639
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
190
Price
$576.80
Total Value
$109.59K
Shares Held After
332,919
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
130
Price
$575.32
Total Value
$74.79K
Shares Held After
333,109
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$573.39
Total Value
$22.94K
Shares Held After
333,239
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$571.76
Total Value
$91.48K
Shares Held After
333,279
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$570.08
Total Value
$91.21K
Shares Held After
333,439
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$565.09
Total Value
$90.41K
Shares Held After
333,599
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
110
Price
$563.98
Total Value
$62.04K
Shares Held After
333,759
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
74
Price
$562.97
Total Value
$41.66K
Shares Held After
333,869
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
500
Price
$37.52
Total Value
$18.76K
Shares Held After
54,645
% of Holdings
0.9%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
165
Price
$416.67
Total Value
$68.75K
Shares Held After
218,164
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
255
Price
$415.67
Total Value
$105.99K
Shares Held After
218,329
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
125
Price
$413.05
Total Value
$51.63K
Shares Held After
218,584
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
211
Price
$412.20
Total Value
$86.97K
Shares Held After
218,709
% of Holdings
0.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
605
Price
$411.32
Total Value
$248.85K
Shares Held After
218,920
% of Holdings
0.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
627
Price
$409.89
Total Value
$257.00K
Shares Held After
219,525
% of Holdings
0.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
962
Price
$408.26
Total Value
$392.74K
Shares Held After
220,152
% of Holdings
0.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
200
Price
$406.50
Total Value
$81.30K
Shares Held After
221,114
% of Holdings
0.1%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Parisotto Shannon M — CEVP, Disc&Safety Assessment
Shares
2,156
Price
$344.41
Total Value
$742.55K
Shares Held After
4,807
% of Holdings
31.0%
Allogene Therapeutics, Inc. (ALLO)
Parker Geoffrey M. — CHIEF FINANCIAL OFFICER
Shares
36,342
Price
$1.34
Total Value
$48.70K
Shares Held After
1,045,877
% of Holdings
3.4%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
2,595
Price
$28.94
Total Value
$75.10K
Shares Held After
198,937
% of Holdings
1.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
100
Price
$94.91
Total Value
$9.49K
Shares Held After
211,930
% of Holdings
0.0%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
2,000
Price
$93.71
Total Value
$187.42K
Shares Held After
212,030
% of Holdings
0.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
2,000
Price
$92.66
Total Value
$185.32K
Shares Held After
214,030
% of Holdings
0.9%
858 transactions